Chaperonin 10 for rheumatoid arthritis - Authors' reply

Lancet

Volumn 368, Issue 9551, 2006, Pages 1961-1962

  Vanags, D ^a   Williams, B ^a   Johnson, B ^a   Feeney, D ^a  

^a Brisbane Technology Park   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CHAPERONIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR;

ANTIGEN EXPRESSION; BLOOD SAMPLING; CANCER PATIENT; CROSS TOLERANCE; DRUG SAFETY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; LETTER; LEWIS CARCINOMA; MELANOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TUMOR GROWTH; DOWN REGULATION; DRUG EFFECT; NOTE;

CHAPERONIN 10; DOWN-REGULATION; HUMANS; TOLL-LIKE RECEPTORS;

EID: 33751425422     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69800-0     Document Type: Letter

References (2)

1. Akyol S., Gercel-Taylor C., Reynolds L., and Taylor D. HSP-10 in ovarian cancer: expression and suppression of T-cell signaling. Gynecol Oncol 101 (2006) 481-486
2. Johnson B., Le T., Dobbin C., et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem 280 (2005) 4037-4047